StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies operating margin

Operating margin is operating income as a percentage of revenue.

AXIM Biotechnologies's operating margin for the twelve months ending Jun 30, 2024 was -2490.3%. For fiscal 2023 it was -6961.0%, against -52425.6% the year before. The highest annual figure on record is -388.9% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-6961.0%+45464.6
FY2022Dec 31, 2022-52425.6%−29311.1
FY2021Dec 31, 2021-23114.5%−22725.6
FY2019Dec 31, 2019-388.9%+2185.7
FY2018Dec 31, 2018-2574.5%+4045.0
FY2017Dec 31, 2017-6619.5%+1369.3
FY2016Dec 31, 2016-7988.8%+12462.4
FY2015Dec 31, 2015-20451.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-3257.9%+3769.3
Q1 FY2024Mar 31, 2024-758.0%+8849.1
Q4 FY2023Dec 31, 2023-5863.1%+9245.5
Q3 FY2023Sep 30, 2023-6142.7%+94155.6
Q2 FY2023Jun 30, 2023-7027.2%+151997.6
Q1 FY2023Mar 31, 2023-9607.1%+30733.2
Q4 FY2022Dec 31, 2022-15108.6%−446.2
Q3 FY2022Sep 30, 2022-100298.3%−97639.7
Q4 FY2021Dec 31, 2021-159024.8%−158953.7
Q3 FY2021Sep 30, 2021-40340.3%−26896.4
Q2 FY2021Jun 30, 2021-14662.4%−14229.4
Q1 FY2021Mar 31, 2021-2658.6%+12377.2
Q4 FY2019Dec 31, 2019-71.1%+16334.6
Q1 FY2019Mar 31, 2019-13443.9%+847.2
Q4 FY2018Dec 31, 2018-433.1%+6363.0
Q3 FY2018Sep 30, 2018-15035.8%−2891.4
Q2 FY2018Jun 30, 2018-16405.7%−4708.3
Q1 FY2018Mar 31, 2018-14291.1%−11733.0
Q4 FY2017Dec 31, 2017-6796.1%−489.5
Q3 FY2017Sep 30, 2017-12144.4%+4059.5
Q2 FY2017Jun 30, 2017-11697.4%−7325.2
Q1 FY2017Mar 31, 2017-2558.1%+4169.3
Q4 FY2016Dec 31, 2016-6306.6%+34615.4
Q3 FY2016Sep 30, 2016-16203.9%−8377.5
Q2 FY2016Jun 30, 2016-4372.3%+8511.7
Q1 FY2016Mar 31, 2016-6727.5%–
Q4 FY2015Dec 31, 2015-40922.0%–
Q3 FY2015Sep 30, 2015-7826.4%–
Q2 FY2015Jun 30, 2015-12883.9%–

More AXIM Biotechnologies figures

See a number that looks wrong?